Angiogenèse tumorale: faits et espoirs = Tumour angiogenesis: facts and hopesTOBELEM, Gérard.STV. Sang thrombose vaisseaux. 2003, Vol 15, Num 9-10, pp 481-485, issn 0999-7385, 5 p.Article

Endogenous inhibitors of angiogenesisNYBERG, Pia; LIANG XIE; KALLURI, Raghu et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 3967-3979, issn 0008-5472, 13 p.Article

Nouveaux antiangiogéniques: état de la recherche : Antiangiogéniques et cancer colorectal métastatique = Update on novel antiangiogenic compoundsJOUINOT, Anne; DREYER, Chantal; BOUATTOUR, Mohamed et al.Cancéro digest. 2010, Vol 2, Num 3, pp 199-204, issn 1953-5171, 6 p.Article

Inhibitors of Angiogenesis: New Hopes for Oncologists, New Challenges for AnesthesiologistsLIBERT, Nicolas; TOURTIER, Jean-Pierre; VEDRINE, Lionel et al.Anesthesiology (Philadelphia). 2010, Vol 113, Num 3, pp 704-712, issn 0003-3022, 9 p.Article

Angiogenesis inhibitors: Current & future directionsMOUSA, Shaker A; MOUSA, Ahmed S.Current pharmaceutical design. 2004, Vol 10, Num 1, pp 1-9, issn 1381-6128, 9 p.Article

Place des traitements antiangiogéniques dans le traitement des tumeurs endocrines peu différenciées = Targeted anti-angiogenics therapies for poorly differenciated neuroendocrine tumoursDAHAN, Laetitia; SEITZ, Jean-François.Hépato-gastro (Montrouge). 2011, Vol 18, issn 1253-7020, S31-S33, SUP2Article

Chimiothérapie métronomique en 2011: actualités et perspectives = Metronomic chemotherapy in 2011: update and perspectivesBENBRAHIM, Zineb; MASSARD, Christophe; EL MESBAHI, Omar et al.Bulletin du cancer. 2011, Vol 98, Num 12, pp 1447-1454, issn 0007-4551, 8 p.Article

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic TherapyBAGLEY, Rebecca G; YI REN; TEICHER, Beverly A et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 976-988, issn 1078-0432, 13 p.Article

The Angiogenesis Inhibitor Thrombospondin-1 Inhibits Acute Cutaneous Hypersensitivity ReactionsVELASCO, Paula; HUEGEL, Rainer; BRASCH, Jochen et al.Journal of investigative dermatology. 2009, Vol 129, Num 8, pp 2022-2030, issn 0022-202X, 9 p.Article

Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimusDEL BUFALO, Donatella; CIUFFREDA, Ludovica; TRISCIUOGLIO, Daniela et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5549-5554, issn 0008-5472, 6 p.Article

Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment BreaksEBOS, John M. L; PILI, Roberto.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3719-3721, issn 1078-0432, 3 p.Article

Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuliCHATTERJEE, Madhumita; ZHANGSEN HUANG; WEI ZHANG et al.Blood. 2011, Vol 117, Num 14, pp 3907-3911, issn 0006-4971, 5 p.Article

Antiangiogenesis Enhances Intratumoral Drug RetentionJIE MA; CHEN, Chong-Sheng; BLUTE, Todd et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 7, pp 2675-2685, issn 0008-5472, 11 p.Article

Histidine-Rich Glycoprotein Modulates the Anti-Angiogenic Effects of VasculostatinKLENOTIC, Philip A; PING HUANG; PALOMO, Juan et al.The American journal of pathology. 2010, Vol 176, Num 4, pp 2039-2050, issn 0002-9440, 12 p.Article

Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF₁₆₅ binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complexSTARZEC, Anna; LADAM, Patrick; VASSY, Roger et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 12, pp 2397-2402, issn 0196-9781, 6 p.Article

AfliberceptCIOMBOR, Kristen K; BERLIN, Jordan; CHAN, Emily et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 1920-1925, issn 1078-0432, 6 p.Article

Thrombospondin-1: Multiple Paths to InflammationLOPEZ-DEE, Zenaida; PIDCOCK, Kenneth; GUTIERREZ, Linda S et al.Mediators of inflammation. 2011, Vol 2011, Num 2, issn 0962-9351, 296069.1-296069.10Article

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesisBOCK, Felix; ONDERKA, Jasmine; DIETRICH, Tina et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 6, pp 2545-2552, issn 0146-0404, 8 p.Article

Antiangiogenic properties of gold nanoparticlesMUKHERJEE, Priyabrata; BHATTACHARYA, Resham; PING WANG et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3530-3534, issn 1078-0432, 5 p.Article

Semaphorin-3F is an inhibitor of tumor angiogenesisKESSLER, Ofra; SHRAGA-HELED, Niva; LANGE, Tali et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 1008-1015, issn 0008-5472, 8 p.Article

Anti-angiogenic therapy: Rationale, challenges and clinical studiesLONGO, R; SARMIENTO, R; FANELLI, M et al.Angiogenesis (London). 2002, Vol 5, Num 4, pp 237-256, issn 0969-6970, 20 p.Article

Meta-analysis of dermatological toxicities associated with sorafenibZHANG, L; ZHOU, Q; MA, L et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 4, pp 344-350, issn 0307-6938, 7 p.Article

Urotensin-II as an angiogenic factorGUIDOLIN, Diego; ALBERTIN, Giovanna; RIBATTI, Domenico et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 6, pp 1219-1224, issn 0196-9781, 6 p.Article

Expression of Vasohibin, an Antiangiogenic Factor, in Human Choroidal Neovascular MembranesWAKUSAWA, Ryosuke; ABE, Toshiaki; SATO, Hajime et al.American journal of ophthalmology. 2008, Vol 146, Num 2, pp 235-243, issn 0002-9394, 9 p.Article

Synthesis and Anti-Angiogenic Activity of Cortistatin AnalogsSATO, Yuuki; KAMIYAMA, Hiroshi; USUI, Takeo et al.Bioscience, biotechnology, and biochemistry. 2008, Vol 72, Num 11, pp 2992-2997, issn 0916-8451, 6 p.Article